<DOC>
	<DOCNO>NCT02234544</DOCNO>
	<brief_summary>Double-blind randomize control trial evaluate serum level 25 ( OH ) D single oral dose cholecalciferol 50,000 IU plus ezetimibe placebo . Differences serum level 25 ( OH ) D response cholecalciferol plus ezetimibe compare cholecalciferol plus placebo .</brief_summary>
	<brief_title>Effect Inhibitor Cholesterol Absorption Vitamin D Levels</brief_title>
	<detailed_description>Objectives : To evaluate serum level 25 ( OH ) D single oral dose cholecalciferol 50,000 IU plus ezetimibe placebo . Experimental design : Double-blind randomized control trial . Research location : Porto Alegre Clinical Hospital ( HCPA ) , RS , Brazil . Participants : Medical resident HCPA . Intervention : The group randomize ezetimibe 10 mg 5 day placebo . On fifth day , come overnight fast blood test collection [ 25 ( OH ) D , PTH , calcium , albumin ] . Next , participant receive orally cholecalciferol 50,000 IU capsule snack contain 15g fat . Participants return 14 day second blood test . Statistical Analysis : Paired sample t-test Wilcoxon sign rank-test used comparing variable two distinct moment ( cholecalciferol 14 day ) . The correlation numerical variable evaluate Spearman 's correlation coefficient . A p value le 0.05 consider statistically significant . Expected result : Differences serum level 25 ( OH ) D response cholecalciferol plus ezetimibe compare cholecalciferol plus placebo . Cost/benefit project : This low budget minimal risk study contribute good understand absorptive process vitamin D effect ezetimibe absorption .</detailed_description>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<criteria>Medical student HCPA Body mass index &gt; + 25 &lt; 18.5 kg/m2 Known liver , kidney endocrine disease Known malabsorption Use supplement calcium and/or vitamin Danticonvulsants , barbiturates , glucocorticoid Travel outside Brazilian south region previous 120 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>vitamin D</keyword>
	<keyword>absorption</keyword>
	<keyword>ezetimibe</keyword>
</DOC>